Ngā hua rapu - Jordan, Justin

Whakamahine hua
  1. 1
    Unrecognized cobalamin deficiency, nitrous oxide, and reversible subacute combined degeneration

    Unrecognized cobalamin deficiency, nitrous oxide, and reversible subacute combined degeneration mā Jordan, Justin T., Weiser, Julia, Van Ness, Paul C.

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    PALL-08. HOSPICE USE AMONG PATIENTS WITH HIGH GRADE GLIOMAS

    PALL-08. HOSPICE USE AMONG PATIENTS WITH HIGH GRADE GLIOMAS mā Forst, Deborah, Adams, Eric, Nipp, Ryan, Martin, Allison, Aizer, Ayal, Jordan, Justin

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Education Research: Neurology resident education: Trending skills, confidence, and professional preparation

    Education Research: Neurology resident education: Trending skills, confidence, and professional preparation mā Jordan, Justin T., Mayans, David, Schneider, Logan, Adams, Nellie, Khawaja, Ayaz M., Engstrom, John

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    ACTR-36. A SINGLE ARM PHASE 2 STUDY OF THE DUAL mTORC1/mTORC2 INHIBITOR VISTUSERTIB PROVIDED ON AN INTERMITTENT SCHEDULE FOR NEUROFIBROMATOSIS 2 PATIENTS WITH PROGRESSIVE OR SYMPTOMATIC MENINGIOMAS

    ACTR-36. A SINGLE ARM PHASE 2 STUDY OF THE DUAL mTORC1/mTORC2 INHIBITOR VISTUSERTIB PROVIDED ON AN INTERMITTENT SCHEDULE FOR NEUROFIBROMATOSIS 2 PATIENTS WITH PROGRESSIVE OR SYMPTO... mā Plotkin, Scott, Jordan, Justin, Beauchamp, Roberta, Muzikansky, Alona, Stemmer-Rachamimov, Anat, Ramesh, Vijaya

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    INNV-20. UTILITY OF TELEHEALTH FOR SPECIALTY NEUROFIBROMATOSIS (NF) CARE

    INNV-20. UTILITY OF TELEHEALTH FOR SPECIALTY NEUROFIBROMATOSIS (NF) CARE mā Jordan, Justin, Seijo, Marlon, Merker, Vanessa, Bhadola, Shivkumar, Thalheimer, Raquel, Plotkin, Scott R

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    NIMG-66. LONG-TERM FOLLOW-UP OF NEUROFIBROMATOSIS TYPE 1 PATIENTS USING WHOLE-BODY MRI DEMONSTRATES DYNAMIC CHANGES IN INTERNAL NEUROFIBROMA SIZE

    NIMG-66. LONG-TERM FOLLOW-UP OF NEUROFIBROMATOSIS TYPE 1 PATIENTS USING WHOLE-BODY MRI DEMONSTRATES DYNAMIC CHANGES IN INTERNAL NEUROFIBROMA SIZE mā Ly, Ina, Thalheimer, Raquel, Cai, Wenli, Bredella, Miriam, Merker, Vanessa, Plotkin, Scott, Jordan, Justin

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Hospice utilization in patients with malignant gliomas

    Hospice utilization in patients with malignant gliomas mā Forst, Deborah, Adams, Eric, Nipp, Ryan, Martin, Allison, El-Jawahri, Areej, Aizer, Ayal, Jordan, Justin T

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Increasing access to specialty care for rare diseases: a case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis

    Increasing access to specialty care for rare diseases: a case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schw... mā Merker, Vanessa L., Dai, Annie, Radtke, Heather B., Knight, Pamela, Jordan, Justin T., Plotkin, Scott R.

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Effective Provider-Patient Communication of a Rare Disease Diagnosis: A Qualitative Study of People Diagnosed with Schwannomatosis

    Effective Provider-Patient Communication of a Rare Disease Diagnosis: A Qualitative Study of People Diagnosed with Schwannomatosis mā Merker, Vanessa L., Plotkin, Scott R., Charns, Martin P., Meterko, Mark, Jordan, Justin T., Elwy, A. Rani

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition

    mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition mā Beauchamp, Roberta L., Erdin, Serkan, Witt, Luke, Jordan, Justin T., Plotkin, Scott R., Gusella, James F., Ramesh, Vijaya

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialists

    Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialists mā Merker, Vanessa L., Knight, Pamela, Radtke, Heather B., Yohay, Kaleb, Ullrich, Nicole J., Plotkin, Scott R., Jordan, Justin T.

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Cost-effectiveness of IDH testing in diffuse gliomas according to the 2016 WHO classification of tumors of the central nervous system recommendations

    Cost-effectiveness of IDH testing in diffuse gliomas according to the 2016 WHO classification of tumors of the central nervous system recommendations mā DeWitt, John C, Jordan, Justin T, Frosch, Matthew P, Samore, Wesley R, Iafrate, A John, Louis, David N, Lennerz, Jochen K

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Correlation between NF1 genotype and imaging phenotype on whole-body MRI: NF1 radiogenomics

    Correlation between NF1 genotype and imaging phenotype on whole-body MRI: NF1 radiogenomics mā Liu, Yunpeng, Jordan, Justin T., Bredella, Miriam A., Erdin, Serkan, Walker, James A., Vangel, Mark, Harris, Gordon J., Plotkin, Scott R., Cai, Wenli

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    NIMG-07. LONG-TERM FOLLOW-UP OF SCHWANNOMA GROWTH BEHAVIOR IN ADULT NEUROFIBROMATOSIS TYPE 2 AND SCHWANNOMATOSIS PATIENTS USING WHOLE-BODY MRI

    NIMG-07. LONG-TERM FOLLOW-UP OF SCHWANNOMA GROWTH BEHAVIOR IN ADULT NEUROFIBROMATOSIS TYPE 2 AND SCHWANNOMATOSIS PATIENTS USING WHOLE-BODY MRI mā Ly, Ina, Thalheimer, Raquel, Cai, Wenli, Bredella, Miriam, Muzikansky, Alona, Merker, Vanessa, Herr, Hamilton, Da, Jennifer, Harris, Gordon, Plotkin, Scott, Jordan, Justin

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    The impact of the COVID-19 pandemic on neurofibromatosis clinical care and research

    The impact of the COVID-19 pandemic on neurofibromatosis clinical care and research mā Radtke, Heather B., Klein-Tasman, Bonita P., Merker, Vanessa L., Knight, Pamela, Ullrich, Nicole J., Jordan, Justin T., Korf, Bruce, Plotkin, Scott R.

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI

    DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI mā Zhang, Jian-Wei, Chen, Wei, Ly, K. Ina, Zhang, Xubin, Yan, Fan, Jordan, Justin, Harris, Gordon, Plotkin, Scott, Hao, Pengyi, Cai, Wenli

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities

    The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities mā Klesse, Laura J., Jordan, Justin T., Radtke, Heather B., Rosser, Tena, Schorry, Elizabeth, Ullrich, Nicole, Viskochil, David, Knight, Pamela, Plotkin, Scott R., Yohay, Kaleb

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Quality improvement in neurology: Neuro-Oncology Quality Measurement Set

    Quality improvement in neurology: Neuro-Oncology Quality Measurement Set mā Jordan, Justin T, Sanders, Amy E, Armstrong, Terri, Asher, Tony, Bennett, Amy, Dunbar, Erin, Mohile, Nimish, Nghiemphu, P Leia, Smith, Timothy R, Ney, Douglas E

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Mind-Body Treatment for International English-Speaking Adults With Neurofibromatosis via Live Videoconferencing: Protocol for a Single-Blind Randomized Controlled Trial

    Mind-Body Treatment for International English-Speaking Adults With Neurofibromatosis via Live Videoconferencing: Protocol for a Single-Blind Randomized Controlled Trial mā Vranceanu, Ana-Maria, Zale, Emily L, Funes, Christopher J, Macklin, Eric A, McCurley, Jessica, Park, Elyse R, Jordan, Justin T, Lin, Ann, Plotkin, Scott R

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Temozolomide therapy for aggressive functioning pituitary adenomas refractory to surgery and radiation: a case series

    Temozolomide therapy for aggressive functioning pituitary adenomas refractory to surgery and radiation: a case series mā Jordan, Justin T, Miller, Julie J, Cushing, Tucker, Seijo, Marlon, Batchelor, Tracy T, Arrillaga-Romany, Isabel C, Shih, Helen A, Nachtigall, Lisa B, Loeffler, Jay S, Dietrich, Jorg

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: